Inventor

Laurence E. Burgess

Inventor

Boulder, CO, US

Overview

1997–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds32%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%

A61KPreparations for medical, dental or toiletry purposes25%

Y02ATechnologies for adaptation to climate change7%

C07CAcyclic or carbocyclic compounds5%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%

H05KPrinted circuits2%

C07KPeptides1%

PatentTitleYear

10,730,8804,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors2020 10,689,377KRas G12C inhibitors2020 10,633,381KRas G12C inhibitors2020 10,189,8454,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors2019 10,125,134KRas G12C inhibitors2018 9,718,796'Substituted benzoazepines as toll-like receptor modulators'2017 9,655,904'Substituted benzoazepines as toll-like receptor modulators'2017 9,556,139'6-substituted phenoxychroman carboxylic acid derivatives'2017 9,242,964'Substituted benzoazepines as toll-like receptor modulators'2016 9,126,940'Substituted benzoazepines as toll-like receptor modulators'2015 9,096,567'6-substituted phenoxychroman carboxylic acid derivatives'2015 8,962,596'5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases'2015 8,785,445'7-phenoxychroman carboxylic acid derivatives'2014 8,716,498'6-substituted phenoxychroman carboxylic acid derivatives'2014 8,691,809'Substituted benzoazepines as toll-like receptor modulators'2014 8,569,522'6-substituted phenoxychroman carboxylic acid derivatives'2013 8,524,702'Substituted benzoazepines as toll-like receptor modulators'2013 8,404,681'Xanthones, thioxanthones and acridinones as DNA-PK inhibitors'2013 8,242,115'Materials and methods to potentiate cancer treatment'2012 8,044,083'Kinase inhibitors and methods of use thereof'2011 8,026,233'P38 inhibitors and methods of use thereof'2011 7,732,446'Dipeptidyl peptidase inhibitors'2010 7,678,909'Dipeptidyl peptidase inhibitors'2010 7,608,618'Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1'2009 7,553,842'Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases'2009 7,226,906'Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases'2007 7,179,912'Materials and methods to potentiate cancer treatment'2007 7,176,229'Cyclic AMP-specific phosphodiesterase inhibitors'2007 7,169,926'Dipeptidyl peptidase inhibitors'2007 7,067,506'Compounds useful for inhibiting Chk1'2006 6,998,416'Cyclic AMP-specific phosphodiesterase inhibitors'2006 6,716,871'Cyclic AMP-specific phosphodie sterase inhibitors'2004 6,680,336'Cyclic AMP-specific phosphodiesterase inhibitors'2004 6,586,467'Preparation of phosphatase inhibitors'2003 6,458,787'Cyclic AMP-specific phosphodiesterase inhibitors'2002 6,423,710'Cyclic AMP-specific phosphodiesterase inhibitors'2002 6,376,489'Cyclic AMP-specific phosphodiesterase inhibitors'2002 6,362,216'Compounds which inhibit tryptase activity'2002 6,258,833'Cyclic AMP-specific phosphodiesterase inhibitors'2001 6,221,914'Sulfonamide bridging compounds that inhibit tryptase activity'2001 6,077,864'Cyclic sulfone derivatives'2000 5,883,131'Cyclic sulfone derivatives'1999 5,648,502'Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997Based in Gales Ferry, CT, US· patent location history

1999–2020Based in Boulder, CO, US· patent location history

2001–2020Patents assigned to ARRAY BIOPHARMA INC (25)· patent assignee history

2001–2009Patents assigned to ICOS CORP (10)· patent assignee history

2012–2017Patents assigned to BURGESS LAURENCE E (8)· patent assignee history

2013–2017Patents assigned to VENTIRX PHARMACEUTICALS INC (6)· patent assignee history

2013–2014Patents assigned to DOHERTY GEORGE A (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ARRAY BIOPHARMA INC	25	2001–2020
ICOS CORP	10	2001–2009
BURGESS LAURENCE Eself	8	2012–2017
VENTIRX PHARMACEUTICALS INC	6	2013–2017
DOHERTY GEORGE A	3	2013–2014

Locations

Location	Patents	Span
Boulder, CO, US	42	1999–2020
Gales Ferry, CT, US	1	1997